NEW YORK, Oct. 9, 2014 /PRNewswire/ -- Harwood Feffer LLP
(www.hfesq.com) is investigating potential claims against the board
of directors of Gentiva Health Services, Inc. ("Gentiva" or the
"Company") (NASDAQ: GTIV) concerning the proposed acquisition of
the Company by Kindred Healthcare Inc.
("Kindred").
On October 9, 2014, the Company
announced that it had agreed to a transaction under which Kindred
will pay $14.50 in cash and
$5 of Kindred common stock for each
share of Gentiva.
On May 13, 2014, the Gentiva Board
of Directors rejected an unsolicited acquisition offer by Kindred
worth approximately $533 million in
cash and stock, or approximately $14
per share. According to correspondence between the two
companies, Gentiva also rejected a $13 per share offer from Kindred in April.
Our investigation concerns whether the Gentiva board of
directors is fulfilling its fiduciary duties, maximizing the value
of the Company, disclosing all material benefits and costs, and
obtaining full and fair consideration for Company
shareholders.
If you own Gentiva shares and wish to discuss this matter with
us, or have any questions concerning your rights and interests with
regard to this matter, please contact:
Benjamin I. Sachs-Michaels,
Esq.
Robert I. Harwood, Esq.
Harwood Feffer LLP
488 Madison Avenue
New York, New York 10022
Phone Numbers: (877) 935-7400
(212)935-7400
Email: bsachsmichaels@hfesq.com
Website: http://www.hfesq.com
Harwood Feffer has been
representing individual and institutional investors for many years,
serving as lead counsel in numerous cases in federal and state
courts. Please visit the Harwood Feffer LLP website
(http://www.hfesq.com) for more information about the firm.
Attorney Advertising. The law firm responsible for this
advertisement is Harwood Feffer LLP (www.hfesq.com). Prior results
do not guarantee or predict a similar outcome with respect to any
future matter.
Logo -
http://photos.prnewswire.com/prnh/20120215/MM54604LOGO
SOURCE Harwood Feffer LLP